Patient adherence is a major determinant of the therapeutic response to antimalarial drugs,
as most treatments are taken at home without medical supervision. With the introduction of …

The aim of this review is to determine the extent of irrational drug use and contributing
factors in Sudan and to identify the interventions that need to be strengthened to promote the …

Background Prescription practices have been shown to influence the emergence of anti-
malarial drug resistance. Thus efforts in this study were devoted to evaluating the …

Background The present paper reports on studies that evaluated artesunate+ sulfadoxine-
pyrimethamine (AS+ SP) which is the first-line drug and artemether-lumefantrine (AL) which …

Abstract Background In Sudan, chloroquine (CQ) remains the most frequently used drug for
falciparum malaria for more than 40 years. The change to artemisinin-based combination …

Background Irrational prescribing and dispensing of antimalarials has been identified as a
contributing factor in the emergence of malaria parasites resistant to existing antimalarial …

In 2004, Sudan adopted artesunate+ sulfadoxine/pyrimethamine (SP) combination as the
first-line drug, in response to the high level of falciparum resistance to antimalarials. In 2007 …

Background The epidemiology of fevers and their management in areas of low malaria
transmission in Africa is not well understood. The characteristics of fever, its treatment and …

Studies done between 1997 and 2003 are reviewed to give an overall picture of antimalarial
drug resistance in the Eastern Mediterranean Region of the World Health Organization [‎ …

Pregnant Sudanese women who presented at a hospital in eastern Sudan with chloroquine-
resistant falciparum malaria were randomly allocated to one of two quinine regimens: low …